SCHEMBL14745239

SCHEMBL14745239

CCc1cc(C(=O)Oc2c(CC)c(-c3ccc(F)cc3)[nH]c(=O)c2C(=O)O)c(=O)[nH]c1-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 2/20 0.43
PDE3A Q14432 2/20 0.43
DHODH Q02127 1/20 0.39
SERPINE1 P05121 1/20 0.35
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34
TUBB4B P68371 1/20 0.34
TUBB3 Q13509 1/20 0.34
TUBB2A Q13885 1/20 0.34
TUBB8 Q3ZCM7 1/20 0.34
TUBA3E Q6PEY2 1/20 0.34
TUBA1A Q71U36 1/20 0.34
TUBA1C Q9BQE3 1/20 0.34
TUBB6 Q9BUF5 1/20 0.34
TUBB2B Q9BVA1 1/20 0.34
TUBB1 Q9H4B7 1/20 0.34
PARP1 P09874 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14745820 0.92 SMN1; SMN2 (0.38) PDE3BPDE3ARXFP1
SCHEMBL14745816 0.84 PDE3B (0.43) PDE3BPDE3APARP1PARP3RXFP1
SCHEMBL14745238 0.83 SERPINE1 (0.42) PDE3BPDE3ADHODHSERPINE1
SCHEMBL14745499 0.83 PDE3B (0.43) PDE3BPDE3ADHODHPARP1PARP3
SCHEMBL14741114 0.77 SERPINE1 (0.42) PDE3BPDE3ASERPINE1PARP1PARP3
SCHEMBL14745819 0.76 GSK3B (0.43) PDE3BPDE3ASERPINE1RXFP1
SCHEMBL14745775 0.75 CDC7 (0.31) PDE3BPDE3A
SCHEMBL14745764 0.74 SERPINE1 (0.31) SERPINE1
SCHEMBL14741008 0.73 PDE3B (0.52) PDE3BPDE3ADHODHSERPINE1MDM2
SCHEMBL14740973 0.73 SERPINE1 (0.47) DHODHSERPINE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016039936-A2 MONOCYCLIC SUBSTITUTED 2-PYRIDINONE ANTIBACTERIAL COMPOUNDS PTC THERAPEUTICS, INC. (US) 2016-03-17 WO claimed
EP-2750505-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC Therapeutics, Inc. (US) 2014-07-09 EP disclosed
WO-2013033240-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC THERAPEUTICS, INC. (US) 2013-03-07 WO disclosed